Introduction
BAG-1 was ®rst cloned from mouse cells as a novel protein capable of interacting with the anti-apoptotic protein, Bcl-2. (Takayama et al., 1995) . Cotransfection of mouse BAG-1 (mBAG-1) with Bcl-2 was shown to increase the protection from apoptosis triggered by several stimuli, including staurosporine, anti-Fas antibody and cytolytic T cells (Takayama et al., 1995) . In addition, overexpression of mBAG-1 alone in mouse NIH3T3 and lymphocyte cells can prolong the cell survival in response to apoptotic stimulus or cytokine withdrawal (Takayama et al., 1995; Clevenger et al., 1997) . mBAG-1 was also reported to interact with serine/threonine-speci®c protein kinase Raf-1 and stimulate its kinase activity through a Ras-independent mechanism (Wang et al., 1996) . Recently, mBAG-1 was shown to bind the plasma membrane-associated tyrosine kinase growth factor receptors for hepatocyte growth factor (HGF) and platelet-derived growth factor (PDGF) and enhance their ability to inhibit apoptosis (Bardelli et al., 1996) . In addition, mBAG-1 was the ®rst protein found to inhibit the chaperone activity of hsp70/hsc70 by binding to their ATPase domain . Therefore, BAG-1 was regarded to be a multifunctional protein that regulates several cellular processes, including cell survival, signal transduction and protein refolding.
In an attempt to identify the transcription factors regulating the neural-speci®c expression of human JC virus (JCV), we cloned, from the mouse P19 embryonal carcinoma cell line, a cDNA encoding a protein capable of binding to the JCV promoter and activating viral transcription. Surprisingly, sequence comparison of this protein with those in the GenBank data base revealed 100% identity to mBAG-1 (data not shown; Takayama et al., 1995) . To elucidate the role of BAG-1 in oncogenesis of human cells, we isolated the human homolog of mBAG-1 by screening a HPV16-immortalized human cervical cell cDNA library with mBAG-1 cDNA as a probe. Comparison of the amino acid sequence of human BAG-1 (hBAG-1) with those of GenBank showed 100% identity to a hormonebinding protein, RAP46 (Zeiner and Gehring, 1995) . Recently, hBAG-1 was also independently cloned by Takayama et al. (1996) . Although the hBAG-1 cDNAs isolated by us and the other two groups have almost identical amino acid sequence, dierent molecule sizes of its protein products were noted. hBAG-1 or RAP46 was identi®ed by Zeiner and Gehring (1995) as a protein with a molecular weight of 46 kDa, whereas it was detected by Takayama et al. (1996) as a protein with molecular weight of 34 kDa. In this study, three protein isoforms of hBAG-1 were observed in vitro that had molecular weights of 46 (p46), 33 (p33) and 29 kDa (p29). We examined the cDNA sequence of hBAG-1 and found three potential translation start codon ATGs (AUGs) at nt 276 (AUG1), 411 (AUG2) and 477 (AUG3), respectively. It is possible that the distinct protein products of hBAG-1 identi®ed by dierent groups may resulted from translation initiation from dierent start codon AUGs. To test our hypothesis, we conducted site-directed mutagenesis of hBAG-1 cDNA and analysed its protein products in vitro. Our results provided convincing evidence that p46, p33 and p29 are translated by alternative translation initiation from start codons AUG1, AUG2 and AUG3, respectively. In addition, an extra isoform of hBAG-1 with a molecular weight of 50 kDa (p50) was also observed in vitro and in vivo by us and recently by Packham et al. (1997) . p50 was found to be translated from CUG upstream of AUG1 (Packham et al., 1997) . The molecular mechanism of alternative translation initiation of hBAG-1 mRNA, and the expression and subcellular localization patterns of these four hBAG-1 isoforms were further investigated in this study.
Results

hBAG-1 protein was expressed as four isoforms by alternative translation initiation
To clone the human homolog of mBAG-1, an HPV16-immortalized human cervical cell cDNA library was screened under low stringency conditions with the whole coding sequence of the mBAG-1 cDNA. After screening 5610 5 phage plaques, seven positive clones were identi®ed and sequenced. The longest cDNA (clone B5-2) had a sequence of 1312 bp containing an open reading frame encoding a protein of 274 amino acids and was identi®ed as hBAG-1. A search for sequences homologous to our hBAG-1 cDNA in the GenBank and EMBL databases revealed 100% identity to RAP46, a gene encoding a hormone receptorbinding protein that was recently isolated from a human liver cDNA library (data not shown; Zeiner and Gehring, 1995) and 98% identity to hBAG-1 isolated from a human breast cDNA library (data not shown; Takayama et al., 1996) .
To characterize hBAG-1 protein, we constructed the recombinant plasmid p46 by cloning the hBAG-1 coding region (nt 274 ± 1113), which covers the region between the ®rst start codon ATG1 and stop codon TGA, into a PCR3.1 vector. In vitro transcription/ translation of p46 cDNA resulted in two major bands of 46 kDa (p46) and 33 kDa (p33), and one minor band of 29 kDa, (p29) (Figure 1b) . No translation products were found when rabbit reticulocyte lysate was used as a negative control. A 61 kDa luciferase protein was detected as a positive control for the reaction.
Although the amino acid sequences of hBAG-1 and RAP46 are identical, dierent size of protein products was found by us and two other groups (Zeiner and Gehring, 1995; Takayama et al., 1996) . RAP46 mRNA was translated in vitro into a 46 kDa protein, whereas hBAG-1 isolated by Takayama et al. (1996) was detected as a protein with molecular weight of 34 kDa. Since there are three AUG start codons in hBAG-1 mRNA at nt 276, 411 and 477 (Figure 2) , respectively, the distinct protein products of hBAG-1, p46, p33 and p29, may have resulted from alternative translation initiation from each of these start codons (Figure 2 ). To test this hypothesis, a series of cDNA constructs containing a single base mutation of each of the three ATGs in p46 cDNA were generated by sitedirected mutagenesis (Figure 1a) . In vitro transcription/ translation of these mutated constructs indicated that p46, p33 and p29 were produced by alternative use of start codon AUG1, AUG2 or AUG3 in hBAG-1 mRNA, respectively. Mutation of any one of these ATGs into TTGs would abolish its function as a translation initiation site and the production of the respective protein product. Mutation of ATG1 into TTG (DATG1) resulted in the loss of the p46 isoform and the generation of only p33 and p29; mutation of the second ATG (DATG2) led to the loss of p33 and the production of p46 and p29; whereas mutation of the third ATG (DATG3) caused the loss of p29 and the generation of p46 and p33 (Figure 1b) . Interestingly, a b Figure 1 Expression of hBAG-1 p46, p33 and p29 isoforms from three alternative translational start sites. (a) Schematic representation of site-speci®c mutagenesis. The p46 cDNA, its mutated constructs and their expected molecular weights in kDa are shown. The mutated ATG start codons were boxed TTGs. The nt for each ATG start codon and the TGA stop codon is indicated below each construct. (b) In vitro transcription/translation of wild type and mutated hBAG-1. cDNAs containing wild type and mutated p46 were in vitro-transcribed/translated in the presence of [
35 S]methionine. The 35 S-labeled protein products were separated by 10% SDS ± PAGE and subsequently detected bȳ uorography. Reticulocyte lysate and luciferase were used as negative and positive controls for the reaction, respectively. Molecular weights in kDa are shown on the left. The positions of p46, p33 and p29 were indicated on the right when the second ATG was mutated (DATG2), the expression of p29 increased signi®cantly.
To con®rm our in vitro transcription/translation results in vivo, we produced anti-hBAG-1 monoclonal antibody (mAb) by immunizing mice with puri®ed p46 protein and examining the expression of hBAG-1 protein in human cervical carcinoma HeLa cells by Western blot. Consistently, p46, p33 and p29 were detected in the cells. However, an extra 50 kDa band, which migrated slower than p46 and was eliminated by competition of anti-hBAG-1 mAb with tenfold excess puri®ed hBAG-1 (data not shown), was also detected by Western blots (Figure 3b ). This protein is either a modi®ed form of hBAG-1 protein or a protein translated from upstream translation start codon. Recently, hBAG-1 was found to be translated from a CUG upstream of AUG1 However, only two hBAG-1 protein products with molecular weight of 50 and 36 kDa were observed both in vitro and in vivo (Packham et al., 1997) . Since the cDNA used previously for in vitro transcription/translation by us and others did not contain the upstream CTG (Zeiner and Gehring, 1995; Takayama et al., 1996) , the absence of p50 in in vitro transcription/translation products may have been due to the absence of translation initiation from this upstream CTG. To test this possibility, we used the cDNA containing upstream CTG (p50) and compared its in vitro translation products with those from p46 cDNA. Interestingly, p50 cDNA produced four protein isoforms with molecular weights of 50, 46, 33 and 29 kDa, respectively ( Figure 3a) . Deletion of the upstream CTG in p46 cDNA resulted in the loss of p50 isoform and the enhanced expression of p46, p33 and p29 ( Figure 3a ). To correlate our in vitro translation results with those in vivo, we compared the expression pattern of hBAG-1 protein products in HeLa cells with those from in vitro transcription/translation of p50 and p46 cDNAs by Western blot. Consistently, four hBAG-1 isoforms of identical size were detected both in HeLa cells and in in vitro translated products of p50 ( Figure  3a and b).
Alternative translation initiation resulted from the leaky scanning mechanism
Alternative initiation of translation is usually caused by the leaking past of the preinitiation scanning complex over the ®rst AUG and the initiation of translation at the downstream start codon when the ®rst AUG codon is not in a perfect Kozak sequence (Kozak, 1989) . Since neither the CTG at nt 63 nor the ®rst two AUG start codons of hBAG-1 mRNA are in a perfect Kozak sequence (Figure 2) , this leaky scanning mechanism may be the cause of alternative initiation of translation Figure 2 Translation of hBAG-1 mRNA may be initiated from one upstream CTG and three potential start codon ATGs. Nucleotide sequence of 5'-end hBAG-1 cDNA was shown. The CTG start codon at nt 63 and three potential start codon ATGs at nt 276, 422 and 477, are boxed and in bold face. The respective protein product, p50, p46, p33 or p29, which was translated from each start codon, is indicated a b c Figure 3 The four hBAG-1 protein isoforms generated by the leaky scanning mechanism. The sequence contexts of CTG and three putative start codon ATGs were modi®ed into the Kozak sequence, respectively. p50K, p46K, p33K and p29K correspond to p50, p46, p33 and p29 cDNA containing the Kozak sequence, respectively. Conditions and labels were as described in Figure 1b (a) In vitro transcription/translation of wild-type and mutated hBAG-1 cDNAs. (b) Detection of hBAG-1 protein in HeLa cells and in vitro-translated protein products by Western blot. Lysate containing 10 mg protein from HeLa cells or 2 ml in vitro translated products were subjected to 10% SDS ± PAGE and transferred to an ECL nitrocellulose membrane. The membrane was subsequently incubated with anti-hBAG-1 mAb (CC9E8), and detected using a goat HRP-conjugated anti-mouse IgG antibody by the ECL method. (c) Expression of the four hBAG-1 isoforms in vivo. The vector control plasmid PCR3.1 and the plasmids containing p50K, p46K, p33K and p29K cDNA were stably transfected into C33A cells. The C33A cells expressing dierent cDNA were lysed in protein lysis buer and 10 mg protein were analysed by Western blot of hBAG-1 mRNA. To prove our hypothesis, we optimized each of the four putative start codons and its surrounding sequences into the Kozak sequence (GCCACCATGG) and analysed the protein products from each mutated constructs both in vitro and in vivo. As expected, optimization of CTG-context or any of the three ATG-context into the Kozak sequence abolished the alternative initiation from its downstream ATGs: when CTG was optimized in Kozak sequence (p50K), only the p50 protein was produced, whereas when ATG1 or ATG2 or ATG3 was in Kozak sequence (p46K, p33K and p29K, respectively), only p46, p33 or p29 protein was translated in vitro, respectively (Figure 3a) . The identity of each in vitro translated product was further con®rmed by Western blot using anti-hBAG-1 mAb (Figure 3b) . Consistent results were found in vivo when p50K, p46K, p33K or p29K cDNA was stably transfected into an hBAG-1 negative cervical cell line C33A cells (Figure 3c ).
hBAG-1 protein was overexpressed in human cancer cell lines and the four isoforms were tissue-speci®c
To examine the role of hBAG-1 in the oncogenesis of human cancers, the expression of hBAG-1 protein was analysed by Western blot using proteins from three types of cultured human normal and cancer cells. Although the expression of hBAG-1 protein was absent or low in normal human endocervical (HEN), ectocervical (HEC), lung (IMR90) or breast (Hs579BST) cells, enhanced expression of p50, p46, p33 or p29 isoform was observed in all cervical (SiHa, HeLa and HT-3), lung (A549, Sk-LU-1 and Sk-MES-1), breast (Hs579T, MCF-7, MDA436 and MDA468) and cancer cell lines (Figure 4) . Interestingly, p50, p46 and p33 were expressed in all the cancer cell lines, whereas p29 was expressed only in cervical cancer cells (SiHa, HeLa and HT-3) and two of four breast cancer cells (MCF-7 and MDA436) (Figure 4) .
Overexpression of hBAG-1 protein in human cancer cells is caused by enhanced transcription of hBAG-1 gene
To study whether the overexpression of hBAG-1 protein in various cancer cells was caused by enhanced transcription or translation, we analysed the expression of hBAG-1 RNA by Northern blot, using RNA from cultured normal and cancer cell lines. Our experiment showed that the expression of hBAG-1 RNA correlated well with that of hBAG-1 protein, suggesting that the overexpression of hBAG-1 protein is caused by increased transcription of the hBAG-1 gene (Figures 4 and 5) .
Distinct isoforms of hBAG-1 protein are dierentially localized in dierent subcellular compartments hBAG-1 contains a putative bipartite nuclear localization signal (NLS) located in aa 149 ± 165 (Zeiner and Gehring, 1995) , suggesting that it may distribute in the nucleus. This is consistent with our ®nding that mBAG-1 functioned as a transcription factor (unpublished data). However, hBAG-1 also interacts with Bcl-2, which is predominantly localized in the nuclear and mitochondria membranes (Krajewski et al., 1993) . Therefore, the subcellular localization of hBAG-1 in HeLa cells was studied by immuno¯uorescence and protein fractionation analysis. As shown in Figure 6 , hBAG-1 protein was localized in both cytoplasm and nucleus. Protein fractionation assay further indicated Figure 4 Overexpression of hBAG-1 protein in cancer cell lines. Western blot analysis was as described in Figure 3b . Labels are as in Figure 1b that hBAG-1 protein was distributed in nuclear, cytosolic and membrane fractions, whereas Bcl-2 was localized in nuclear and membrane fractions but not in the cytosolic fraction (Figure 7a ). Lamin B was used as the nuclear fraction marker and b-tubulin as the cytoplasmic fraction marker (Figure 7a and Joh et al., 1997) . Interestingly, the four isoforms of hBAG-1 were distributed dierently in the cells. The p50 isoform was predominantly present in the nuclear and membrane fractions and p46 was in the fractions from all three compartments, whereas p33 and p29 were found mostly in the cytosol fraction (Figure 7a ). To further con®rm these results, mutated hBAG-1 cDNAs expressing only p50, p46, p33 or p29, was stably transfected into the hBAG-1-negative cervical carcinoma cell line C33A cells. Protein fractionation clearly demonstrated that the distinct isoforms of hBAG-1 were distributed dierently in the cells (Figure 7b ).
Discussion
Using mBAG-1 cDNA probe, we have successfully isolated the human homolog of mouse BAG-1 from a human cervical cell cDNA library. Surprisingly, hBAG-1 has 100% homology with a novel hormone receptor-binding protein, RAP46 (Zeiner and Gehring, 1995) . RAP46 was isolated by screening a human liver cDNA expression library with the glucocorticoid receptor. In addition to interacting with the glucocorticoid receptor, RAP46 also interacted with other human hormone receptors, including estrogen, progesterone and thyroid receptors (Zeiner and Gehring, 1995) . Recently, hBAG-1 was also isolated from a human breast cell cDNA library by Takayama et al. (1996) . However, the three groups identi®ed dierent size of protein products for hBAG-1/RAP46. More recently, a 50 kDa hBAG-1 protein was also observed by Packham et al. (1997) . Our results reconciled the discrepancies observed by others and clearly demonstrated that hBAG-1 was expressed as four isoforms of protein, p50, p46, p33 and p29, which were produced by alternative initiation of translation. In addition, our data suggested that the expression of these distinct forms of proteins are tissue-speci®c. For example, all four hBAG-1 isoforms were expressed in human cervical cancer cell lines, whereas only p50, p46 and p33 were expressed in human lung cancer cell lines (Figure 4) . The absence of p29 in lung cancer cell lines is unlikely to be the result of low expression of hBAG-1 transcription. While A549 had the highest expression of p33 among all the cell lines studied, no p29 was detected in this cell line (Figure 4) . Analogously, three species of mBAG-1 with molecular weights of 50 kDa (p50m), 30 kDa (p30m) and 28 kDa (p28m), respectively, may have been produced by alternative translation as well, since there are two AUG start codons on mBAG-1 mRNA, and the ®rst AUG is not in perfect Kozak sequence. Most interestingly, the expression of mBAG-1 protein in mouse cell lines is also tissue-speci®c. Mouse P19 embryonal carcinoma cells expressed all the three products of mBAG-1, p50m, p30m and p28m, whereas no p28m was Figure 5 Overexpression of hBAG-1 RNA in human cancer cell lines. Twenty mg total RNA from human cervical, breast and lung normal and cancer cells were size-fractionated on a 1.0% agarose formaldehyde gel, transferred to nitrocellulose membranes and hybridized with 32 P-labeled hBAG-1 cDNA probe. Molecular weights in kb are shown on the left. The position of hBAG-1 RNA is indicated by arrowhead expressed in mouse ®broblast NIH3T3 cells (data not shown).
Alternative initiation of translation usually results from a leaky scanning mechanism, in which the preinitiation scanning complex bypasses or`leaks' past the ®rst AUG and initiates at a downstream codon when the ®rst AUG codon is not in a perfect Kozak sequence (GCCA/GCCAUGG) for recognition by the scanning complex (Kozak, 1989) . Since neither the upstream CUG nor the ®rst AUG of hBAG-1 mRNA is in the optimal Kozak sequence, translation may start from the ®rst, second or third AUG. By optimization of CTG-context and each of the three ATGs-context into Kozak sequence, we provided both in vitro and in vivo evidence that alternative initiation of hBAG-1 is caused by the leaky scanning mechanism. Although not common, use of alternative translation initiation sites occurs in other genes such as c-myc (Spotts et al., 1997) , cot (Aoki et al., 1993) and glutathione peroxidase (Pushpa-Rekha et al., 1995) . In addition, proteins translated by alternative initiation of translation from start codon AUGs were previously shown to have dierent transforming activity (Aoki et al., 1993) or transactivation function (Spotts et al., 1997) . It would be of interest to study whether these four isoforms of hBAG-1 have distinct functions in the cells.
Although BAG-1 was originally identi®ed as a Bcl-2-binding protein, its subcellular localization was apparently dierent from that of Bcl-2. Using immuno¯uorescence and protein fractionation, we demonstrated that hBAG-1 proteins were localized in all the cellular compartments, including the nucleus, cytosol and membranes, whereas Bcl-2 was only localized in the nuclear envelope and membranes (Krajewski et al., 1993;  Figure 7a ). Since hormone receptors are distributed in the cytosol and nucleus (Sackey et al., 1996) , hBAG-1 may interact with Bcl-2 on the membranes and with hormone receptors in the cytosol or nucleus. Most importantly, we found that Control DAPI hBAG-1 hBAG-1 (650 X) Figure 6 Subcellular localization of hBAG-1 protein. The subcellular localization of hBAG-1 was analysed by immuno¯uorescence using CC9E8 mAb. Control panel shows the result of immuno¯uorescence analysis without CC9E8. DAPI stain was a control for nuclear staining. All panels are 4006magni®cation, except the indicated magni®cation for the bottom right panel p50 protein was predominantly localized in the nuclear and membrane fraction, whereas p33 and p29 proteins were mostly present in the soluble cytosol. Dierential subcellular localization of alternatively translated proteins was also found for other genes, such as FGF and hck (Bugler et al., 1991; Lock et al., 1991) . Since all the four isoforms of hBAG-1 retain bipartite NLS, the exact mechanism for the cytosolic distribution of p33 and p29 is still unclear at the moment.
However, our results do suggest that the N-terminal sequences present in p50 are important for the nuclear localization of hBAG-1 proteins. Further, since BAG-1 may function as a transcription factor for JCV (unpublished data) and the four isoforms of hBAG-1 were localized in distinct subcellular compartments, we are currently investigating whether distinct isoforms have dierent eects on the transcription activation of JCV. It has been hypothesized that defects in apoptosisregulating genes are involved in the pathogenesis of human cancers (Orrenius, 1995; Thompson, 1995) . This hypothesis is supported by the observations that p53, an inducer of apoptosis, is frequently deleted or mutated in various human cancers, whereas Bcl-2, an inhibitor of apoptosis, is overexpressed in a wide variety of solid tumors. Bcl-2 was ®rst identi®ed as an oncogene that is overexpressed in follicular lymphomas (Tsujimoto and Croce, 1986) . Subsequently, overexpression of bcl-2 was also observed in breast cancer, lung carcinoma, prostate carcinoma, cervical cancer and other cancers (Lu et al., 1993; Haldar et al., 1994; Ikegaki et al., 1994; Liang et al., 1995) . Although overexpression of bcl-2 in NIH3T3 mouse cells resulted in tumor formation in nude mice, elevation of Bcl-2 was insucient to transform immortalized human cells (Lu et al., 1996) . This suggests that additional genes are required for tumorigenesis. In our study, the expression of hBAG-1 RNA and protein was low or negative in normal cervical, breast and lung cells. However, high levels of hBAG-1 mRNA and protein were observed in human cervical carcinoma, breast cancer and lung cancer cell lines (Figures 4 and 5) . Since BAG-1 binds Bcl-2 and enhances its ability to inhibit apoptosis (Takayama et al., 1995) , synergistic action of BAG-1 and bcl-2 may be required in the tumorigenesis of human cells. We are currently testing this hypothesis by analysing hBAG-1 and bcl-2 expression in various human normal and cancer tissues.
Materials and methods
Cell culture and transfection
Human endocervical cells (HEN) and human ectocervical cells (HEC) were cultured in serum-free media for keratinocytes (GIBCO ± BRL). All the other cells used in this study were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% fetal calf serum.
For cervical carcinoma C33A cell (an hBAG-1 negative cell line) transfections, wild type or mutated forms of hBAG-1 cDNA were cloned into an eukaryotic expression vector PCR3.1 (Invitrogen). Approximately 24 h prior to transfection, C33A were seeded at a density of 5610 5 cells per 10-cm culture dish. Plasmid DNAs were stably transfected into C33A cells by calcium chloride method followed by selection in medium containing 0.8 mg/ml G418 (GIBCO ± BRL). The resulting transfectants were maintained as cell lines and harvested for protein subcellular fractionation or Western blot analysis.
Construction and screening of cDNA library and cDNA sequencing
For construction of the cDNA library, total RNA was extracted from the cells at 70% con¯uence using the CsCl a b Figure 7 Distinct subcellular localization of the four hBAG-1 protein isoforms. Protein was either unfractionated (T) or fractionated into nuclear (N), soluble cytosol (C) and high-speed membrane pellet (M) fractions by dierential centrifugation. The unfractionated and fractionated protein samples were analysed by Western blotting with anti-hBAG-1, anti-Bcl-2 and anti-b-tubulin mAbs, and Lamin B polyclonal antibody, respectively. Labels are as described in Figure 1b gradient centrifugation method (Sambrook et al., 1989) . Polyadenylated RNA was isolated from the total RNA using a Quickprep mRNA Puri®cation kit (Pharmacia Biotech Inc.). The cDNA library was constructed from polyadenylated RNA of HPV16-immortalized human endocervical cells, HEN-16-2, using the ZAP-cDNA Synthesis kit (Stratagene). The cDNA library was screened under low stringency conditions using a full-length mBAG-1 cDNA isolated from P19 mouse embryonal carcinoma cell line, as described (Sambrook et al., 1989) . The positive clones were excised from the phage and rescued into pBluescript phagemid using the ExAssist/SOLR system (Stratagene). Double-stranded cDNAs were sequenced using a Sequenase Version 2.0 kit (USB, Cleveland, OH).
Generation of anti-hBAG-1 mAb
The coding region of hBAG-1 cDNA was cloned in-frame into pGEX-4T-3 vector (Pharmacia). The resulting plasmid was then transfected into BL21 bacteria and the GSThBAG-1 fusion protein was induced with 0.1 mM isopropyl b-D-thiogalactoside at 308C for 5 h. hBAG-1 protein was puri®ed by binding GST-hBAG-1 on glutathione-Sepharose-4B beads (Pharmacia) and cleavage with thrombin. The mAb was generated by immunization of mice with puri®ed hBAG-1. After extensive screening, one clone named CC9E8, which recognized all the four isoforms of hBAG-1 and gave the best activity, was selected to produce antihBAG-1 mAb used for Western blot analysis.
Northern blot and Western blot analysis
For Northern blot analysis of normal and cancer cell lines, 20 mg total RNA were separated in denaturing 1% agarose gels and transferred to Hybond nitrocellulose membrane (Amersham). The blots were hybridized in QuickHyb hybridization buer (Amersham) containing 32 P-labelled cDNA probes at 658C for 1 h. The hybridized blots were washed twice with 26SSC/0.1% SDS at room temperature for 15 min and twice with 0.16SSC/0.1% SDS at 658C for 10 min. After washing, the membranes were exposed to Kodak XAR ®lm for 1 ± 5 days. b-actin was used as an internal control.
Western blot analysis was performed as described (Yang et al., 1997) . CC9E8 and goat anti-mouse HRP-conjugated IgG were used as the ®rst and the secondary antibodies, respectively. For testing the speci®city of anti-hBAG-1 mAb, the puri®ed hBAG-1 protein was added to the hybridization reaction in tenfold excess. The bands eliminated by the addition of hBAG-1 protein were regarded as genuine bands.
In vitro mutagenesis
Mutation of hBAG-1 ATG start codon into TTG was carried out by oligonucleotide-directed mutagenesis with QuikChange Site-Directed Mutagenesis kit (Stratagene). Deletion of hBAG-1 and optimization of sequence surrounding hBAG-1 start codon into the Kozak sequence (GCCACCATGG) were carried out by PCR. All mutations were con®rmed by sequencing with Sequenase Version 2.0 kit (USB).
In vitro transcription/translation
Wild-type and mutated hBAG-1 cDNA were transcribed and translated in vitro in the presence of [
35 S]methionine (Amersham) using a coupled transcription/translation system (TNT; Promega), as described by the supplier.
Indirect immuno¯uorescence analysis
For analysis of hBAG-1 subcellular localization, HeLa cells grown on multiwell slides in monolayer culture were ®xed in ice-cold 50% methanol/50% acetone for 30 min, air-dried and stored at room temperature until use. The ®xed cells were consecutively immersed three times in 100% ethanol, three times in 70% ethanol, once in H 2 O, and three times in 16PBS. The slides were incubated in 20% goat serum for 1 h, with mouse anti-hBAG-1 antibody in PBS at 1 : 200 dilution for 1 h, and with FITC-conjugated anti-mouse IgG diluted 1 : 40 in 20% goat serum for 1 h. Staining was visualized by mounting in 30% glycerol and examining under a Leitz Laborlux S Fluorescence Microscope (Germany) in the dark. For nuclear staining, the slides were hydrated as above and then stained with 3 mg/ml 4, 6-diamidino-2-phenylindole (DAPI) for 5 min. For control, anti-hBAG-1 antibody was omitted in the hybridization buer.
Subcellular protein fractionation
About 10
7 HeLa cells were washed twice with PBS, lysed in 500 ml hypotonic lysis buer (10 mM HEPES, pH 7.4, 38 mM NaCl, 25 mg/ml phenylmethylsulfonyl¯uoride and 1 mg/ml aprotinin), homogenized in a Dounce homogenizer and centrifuged at 900 g to pellet the nuclei. The postnuclear supernatant was then centrifuged at 130 000 g at 48C to pellet the membranes. Both the nuclear and membrane pellets were resuspended in 500 ml lysis buer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.02% sodium azide, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate). The cytosolic supernatant was adjusted to 150 mM NaCl, 1% NP-40 and 0.1% SDS. The relative levels of hBAG-1, Bcl-2, Lamin B and b-tubulin in the nuclear, cytosolic and membrane fractions were analysed by Western blot using 10 mg protein for each fraction.
